Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost protection against the new variant later this year.

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn’t have a name, nor did the illness it would cause. It wound up setting off a ...

The Omicron variant first was detected in late ... A week later, an EUA was issued for the Moderna mRNA vaccine. In large clinical trials, both vaccines were shown to be highly effective at ...

The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...

Both Moderna and Pfizer-BioNTech manufacture the ... "At the height of the Omicron wave, we still saw a lot of children being ...